EAM
GOSS icon

Exome Asset Management’s Gossamer Bio GOSS Stock Holding History

Exome Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-451,699
Closed -$1.4M – 64
2025
Q4 		$1.4M Hold
451,699
– – 0.67% 46
2025
Q3 		$1.19M Sell
451,699
-646,300
-59% -$1.42M 0.72% 49
2025
Q2 		$1.35M Hold
1,097,999
– – 1% 45
2025
Q1 		$1.21M Hold
1,097,999
– – 1.07% 38
2024
Q4 		$993K Buy
1,097,999
+629,500
+134% +$539K 0.75% 45
2024
Q3 		$462K Sell
468,499
-659,200
-58% -$634K 0.31% 55
2024
Q2 		$1.02M Buy
+1,127,699
New +$844K 0.9% 37

Other funds holding GOSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Exome Asset Management's GOSS Position: Q1 2026 in Review

Exome Asset Management sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 451,699 shares — an estimated $1.4M sold.

Exome Asset Management first reported a position in GOSS in Q2 2024 and held it in 7 quarters. The position peaked at $1.4M in Q4 2025. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Exome Asset Management reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • Exome Asset Management sold 451,699 Gossamer Bio shares in Q1 2026, an estimated $1.4M.
  • Exome Asset Management first reported a position in Gossamer Bio in Q2 2024 and held it in 7 quarters.
  • Exome Asset Management's Gossamer Bio position peaked at $1.4M in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Exome Asset Management's 13F filing for Q1 2026, filed 15 May 2026.